BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo H, Shan J, Zhang H, Song G, Li Q, Xu CX. Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer. Semin Cancer Biol 2022;86:960-70. [PMID: 35189321 DOI: 10.1016/j.semcancer.2022.02.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Monte-Serrano E, Lazo PA. VRK1 Kinase Activity Modulating Histone H4K16 Acetylation Inhibited by SIRT2 and VRK-IN-1. Int J Mol Sci 2023;24. [PMID: 36902348 DOI: 10.3390/ijms24054912] [Reference Citation Analysis]
2 Li J, Li L, You P, Wei Y, Xu B. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer. Semin Cancer Biol 2023;91:35-49. [PMID: 36868394 DOI: 10.1016/j.semcancer.2023.02.009] [Reference Citation Analysis]
3 Luo H, Song G, Wang D, Li M, Dai N. Combining PD-1 or PD-L1 inhibitors with chemotherapy is a good strategy for the treatment of extensive small cell lung cancer: A retrospective analysis of clinical studies. Front Immunol 2022;13:1059557. [PMID: 36544769 DOI: 10.3389/fimmu.2022.1059557] [Reference Citation Analysis]
4 Niu X, Chen L, Li Y, Hu Z, He F. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC. Semin Cancer Biol 2022;86:273-85. [PMID: 35288298 DOI: 10.1016/j.semcancer.2022.03.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 44.0] [Reference Citation Analysis]
5 Zhang H, Kong W, Liang W. NUT Midline Carcinoma: A Rare Solid Tumour Characterized by Chromosome Rearrangement. Evid Based Complement Alternat Med 2022;2022:3369895. [PMID: 35832518 DOI: 10.1155/2022/3369895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Meijer JJ, Leonetti A, Airò G, Tiseo M, Rolfo C, Giovannetti E, Vahabi M. Small cell lung cancer: novel treatments beyond immunotherapy. Semin Cancer Biol 2022:S1044-579X(22)00115-8. [PMID: 35568295 DOI: 10.1016/j.semcancer.2022.05.004] [Reference Citation Analysis]
7 Yin X, Li Y, Wang H, Jia T, Wang E, Luo Y, Wei Y, Qin Z, Ma X. Small cell lung cancer transformation: From pathogenesis to treatment. Semin Cancer Biol 2022:S1044-579X(22)00062-1. [PMID: 35276343 DOI: 10.1016/j.semcancer.2022.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]